CURRICULUM VITAE
Francisco A. Durazo MD
Francisco A. Durazo MD
Professor
Department of Medicine
Division of Gastroenterology
Department of Medicine
Division of Gastroenterology
OFFICE ADDRESS: |
Froedtert Hospital |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Mundo F., Durazo F. Spontaneous Rupture of an Intra-Abdominal Neuroblastoma Manifested as an Acute Abdomen. Annals of the American British Cowdray Hospital. September 1980. |
2. Durazo F., Valenzuela JE. Effect of a Single and Repeated Doses of Metoclopramide on Mechanisms of Gastroesophageal Reflux. American Journal of Gastroenterology. 1993 Oct;88(10):1657-1662. PMID: 8213706 |
3. Cosenza C, Durazo F, Stain S, Jabour N, Selby R. Current Management of Recurrent Pyogenic Cholangitis. American Surgeon. 1999 Oct;65(10):939-943. PMID: 10515539 |
4. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart and Circ Physiol. 2002;238:H1455-1461. PMID: 12234797 |
5. Ghobrial RM, Saab S, Lassman C, Lu DS, Raman S, Limanond P, Kunder G, Marks K, Amersi F, Anselmo D, Chen P, Farmer D, Han S, Durazo F, Goldstein LI, Busuttil RW. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transplantation. 2002 Oct;8(10):901-909. PMID: 12360431 |
6. Han S, Martin P, Edelstein M, Saab S, Hu R, Kunder G, Holt C, Durazo F, Goldstein L, Farmer D, Ghobrial R, Busuttil R. Conversion from Intravenous to Intramuscular Hepatitis B Immune Globulin in Combination with Lamivudine is Safe and Cost-Effective in Patients Receiving Long-Term Prophylaxis to Prevent Hepatitis B Recurrence after Liver Transplantation. Liver Transplantation. 2003 Feb;9(2):182-187. PMID: 12548512 |
7. Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG, Busuttil RW, Lassman C. Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. American Journal of Transplantation. 2003 Mar;3(3):328-333. PMID: 12614290 |
8. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, Weaver M, Figueroa J, Khan K, Vargas J, Saab S, Han S, Durazo F, Goldstein LI, Holt C, Busuttil RW. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Annals of Surgery. 2003 May;237(5):666-675; discussion 675-676. PMID: 12724633 |
9. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Cost and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. American Journal of Gastroenterology. 2003 98(4):763-770. PMID: 12738453 |
10. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrissey M, Goldstein LI, Ghobrial RM, Busuttil RW. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transplantation. 2003 May;9(5):473-476. PMID: 12740789 |
11. Saab S, Ly David, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S, Farmer D, Ghobrial R, Yersiz, Chen P, Schwegel K, Goldstein L, Tong M, Busuttil R. Hepatocellular Carcinoma Screening in Patients Waiting for Liver Transplantation: A Decision Analytic Model. Liver Transplantation. 2003 Jul;9(7):672-681. PMID: 12827551 |
12. Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW. Hepatitis C Positive Grafts May Be Used in Orthotopic Liver Transplantation: A Matched Analysis. American Journal of Transplantation. Sep;3(9):1167-1172, 2003. PMID: 12919097 |
13. Saab S, Chang AJ, Comulada S, Geevarghese S, Anselmo RDM, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial, RM, Busuttil RW. Outcomes of Hepatitis C- and Hepatitis B Core Antibody- Positive Grafts in Orthotopic Liver Transplantation. Liver Transplantation. 2003 Oct;9(10):1053-1061. PMID: 14526400 |
14. Kanwal F, Chen D, Ting L, Gornbein J, Saab S, Durazo F, Yersiz H, Farmer D, Ghobrial RM, Busuttil RW, Han S. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transplantation. 2003 Dec;9(12):1312-1319. PMID: 14625832 |
15. Durazo F, Lassman C, Han S, Saab S, Lee N, Kawano M, Saggi B, Gordon S, Farmer D, Yersiz H, Goldstein L, Ghobrial RM, Busuttil RW. Fulminant Liver Failure Due to Usnic Acid for Weight Loss. American Journal of Gastroenterology. 2004 May;99(5):950-952. PMID: 15128366 |
16. Saab S, Kalmaz D, Gajjar N, Hiatt J, Durazo F, Han S, Farmer D, Ghobrial RM, Yersiz H, Goldstein L, Lassman C, Busuttil RW. Outcomes of Acute Rejection after Interferon Therapy in Liver Transplant Recipients. Liver Transplantation. 2004 Jul;10(7):859-867. PMID: 15237369 |
17. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transplantation. 2004 Dec;10(12):1478-1486. PMID: 15558585 |
18. Neff GW, Reddy RK, Durazo F, Meyer D, Marrero R, Kaplowitz N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. Journal of Hepatology. 2004 Dec;41(6):1062-1064. PMID: 15582145 |
19. Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. MELD fails to measure quality of life in liver transplant candidates. Liver Transplantation. 2005 Feb;11(2):218-223. PMID: 15666392 |
20. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma as a Bridge to Liver Transplantation. Hepatology. 2005 May;41(5):1130-1137. PMID: 15841454 |
21. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S, Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Annals of Surgery. 2005 Jun;241(6):905-916; discussion 916-918. PMID: 15912040 |
22. Saab S, Niho H, Comulada S, Hiatt J, Durazo F, Han S, Farmer D, Holt C, Yersiz H, Goldstein L, Ghobrial RM, Busuttil RW. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver International. 2005 Oct;25(5):940-945. PMID: 16162150 |
23. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong M, Busuttil R. The MELD score in advanced liver disease: Association with clinical portal hypertension and mortality. Experimental and Clinical Transplantation. 2006 June;(4) 1:395-399. PMID: 16827633 |
24. Saab S, Shpaner A, Zhao Y, Brito I, Durazo F, Han S, Farmer D, Ghobrial RM, Yersiz H, Goldstein L, Tong M, Busuttil RW. Prevalence and risk factors for Diabetes Mellitus in moderate term survivors of liver transplantation. American Journal of Transplantation 2006 Aug;6(8):1890-1895. PMID: 16889544 |
25. Cameron AM, Ghobrial RM, Hiatt JR, Carmody JC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han S, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Annals of Surgery. 2006 Oct;244(4):563-571. PMID: 16998365 |
26. Spiegel B, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan H, Durazo F, Bacon B, Martin P, Younossi Z, Ong SH, Kanwal F. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: The hepatitis B Quality of Life instrument, version 1.0. Hepatology. 2007 Jul;46(1):113-121. PMID: 17596882 |
27. Saab S, Oh MK, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong MJ, Busuttil RW. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver Transplantation. 2007 Jul;13(7):1032-1038. PMID: 17600345 |
28. Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial RM, Goldstein L, Tong M, Busuttil R. Employment and quality of life in liver transplant recipients. Liver Transplantation. 2007 Sep;13(9):1330-1338. PMID: 17763388 |
29. Durazo F, Yan E, Tong MJ. Nonalcoholic fatty liver disease: Identification and treatment. Family Practice Recertification. 2007 Sep;29(9):1-9. |
30. Durazo F, Blatt LB, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2008 Oct;23(10):1541-1548. PMID: 18422961 |
31. Tabibian JH, Lassman CR, Margolis DJ, Landaverde C, Busuttil RW, Durazo F. Intraductal oncocytic papillary neoplasm of the liver: Case and review of a rare variant. Annals of Hepatology. 2008 Apr-Jun;7(2):168-173. PMID: 18626437 |
32. Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Pretransplant variables associated with quality of life in liver transplant recipients. Liver International. 2008 Sep;28(8):1087-1094. PMID: 18662279 |
33. Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, Bolus R, Kim SJ, Gralnek IM. Prospective validation of the short form liver disease quality of life instrument. Alimentary Pharmacology Therapeutics. 2008 Nov 1;28(9):1088-1101. PMID: 18671776 |
34. Shim M, Durazo F. Multinodular fatty liver after herpes-zoster vaccine: case report and review of the literature. Annals of Hepatology. 2008 Oct-Dec;7(4):382-385. PMID: 19034241 |
35. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment with multiple stents for post-liver transplantation nonanastomotic biliary strictures. Gastrointestinal Endoscopy. 2009 Jun;69(7):1236-1243. PMID: 19249040 |
36. Tong MJ, Hsien C, Song JJ, Kao JH, Sun H, Hsu L, Han S, Durazo F, Saab S, Blatt LM. Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Digestive Diseases and Sciences. 2009 Jun;54(6):1337-1346. PMID: 19242792 |
37. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clinical Gastroenterology Hepatology. 2009 Jul;7(7):793-799. PMID: 19306949 |
38. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transplantation. 2009 Nov;15(11):1525-1534. PMID: 19877207 |
39. Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Annals of Hepatology. 2009 Oct-Dec;8(4):379-383. PMID: 20009140 |
40. Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ, Hayashi P, Lee WM, Seeff LB. Hepatotoxicity Due to Hydroxycut: A Case Series. American Journal of Gastroenterology. 2010 Jul;105(7):1561-1566. PMID: 20104221 |
41. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy. Gastrointestinal Endoscopy. 2010 Mar;71(3):505-512. PMID: 20189508 |
42. Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clinical Gastroenterology Hepatology. 2010 Aug;8(8):709-717. PMID: 20385251 |
43. Tong MJ, Hsu L, Hsien C, Kao JH, Durazo F, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International. 2010 Apr 7;4(2):516-522. PMID: 20827410 |
44. Han SH, Durazo FA, Saab S, Tong MJ. A proposed, evidence-based approach to the treatment of chronic hepatitis B. J Clin Gastroenterol. 2011 Mar;45(3):259-266. PMID: 20856136 |
45. Tabibian J, Lazo M, Durazo F, Yeh HC, Clark J. Non-alcoholic fatty liver disease across ethno-racial groups: Do Asian-Americans adults represent a new at-risk population? Journal of Gastroenterology Hepatology. 2011 Mar;26(3):501-509. PMID: 21332546 |
46. Saab S, Desai S, Tsaoi D, Durazo F, Han S, McClune A, Holt C, Farmer D, Goldstein L, Busuttil RW. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. American Journal of Transplantation. 2011 Mar;11(3):511-517. PMID: 21299826 |
47. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. Journal of American College of Surgeons. 2011 Apr;212(4):514-520; discussion 520-521. PMID: 21463781 |
48. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, Farmer D, Busuttil RW. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transplantation. 2011 May;17(5):580-590. PMID: 21506246 |
49. Saab S, Ng V, Landaverde C, Lee SJ, Comulada WS, Arevalo J, Durazo F, Han SH, Younossi Z, Busuttil RW. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transplantation. 2011 May;17(5):567-579. PMID: 21506245 |
50. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: A 24-year experience in a single center. Archives of Surgery. 2011 Jun;146(6):683-689. PMID: 21690444 |
51. Chavalitdhamrong D, Jensen DM, Singh B, Kovacs TO, Han SH, Durazo F, Saab S, Gornbein JA. Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clinical Gastroenterology and Hepatology. 2012 Mar;10(3):254-258. PMID: 22155754 |
52. Agopian V, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo FA, Saab S, Han SB, Xia V, Hiatt JR, Busuttil RW. The Evolution of Liver Transplantation During Three Decades: Analysis of 5347 Consecutive Liver Transplants at a Single Center. Annals of Surgery. 2013 Sep;258(3):409-421. PMID: 24022434 |
53. Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo FA, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW. Liver Transplantation in Highest-Acuity Recipients: Identifying Factors to Avoid Futility. Annals of Surgery. 2014 Jun;259(6):1186-1194. PMID: 24263317 |
54. Lee EW, Saab S, Gomes AS, Busuttil RW, McWilliams J, Durazo F, Han SH, Goldstein L, Tafti BA, Moriarty J, Loh CT, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. Clin Transl Gastroenterol. 2014 Oct 2;5: e61. PMID: 25273155 |
55. Saab S, Manne V, Bau S, Reynolds JA, Allen R, Goldstein L, Durazo F, El Kabany M, Han S, Busuttil RW. Boceprevir in liver transplant recipients. Liver Int. 2015 Jan;35(1):192-197. PMID: 24673728 |
56. Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS. Intraductal Cooling via a Nasobiliary Tube during Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries. Am J Roentgenol. 2015 June;204(6):1329-1335. PMID: 26001245 |
57. Park JK, Saab S, Kee ST, Busuttil RW, Kim HJ, Durazo F, Cho SK, Lee EW. Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci. 2015 Jun;60(6):1543-1553. PMID: 25519690 |
58. Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW. Treating Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin: A Matched Analysis. Clin Transplant. 2015 Sep;29(9):813-819. PMID: 26147216 |
59. Saab S, Greenberg A, Li E, Bau SN, Durazo F, El Kabany M, Han S, Busuttil RW. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. Liver Int. 2015 Nov;35(11):2442-2447. PMID: 25913321 |
60. Lu N, Crespi C, Liu N, Vu J, Ahmadieh Y, Wu S, Lin S, McClune A, Durazo FA, Saab S, Han SB, Neiman D, Beaven S, French S. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Research. 2016 Jan:30(1):160-168. PMID: 26621580 |
61. Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW. Curing Hepatitis C in Liver Transplant Recipients is Associated with Changes in Immunosuppressant use. J Clin Transl Hep. 2016 Mar 28;4(1):32-38 PMID: 27047770 |
62. Flores YN, Auslander A, Crespi CM, Rodriguez M, Zhang ZF, Durazo F, Salmerón J. Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. J Dig Dis. 2016 May;17(5):304-312. PMID: 26991251 |
63. Kuei A, Lee EW, Saab S, Busuttil RW, Durazo F, Han SH, ElKabany M, McWilliams JP, Kee ST. Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012. Dig Dis Sci. 2016 Jun 27. PMID: 27349987 |
64. Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, El-Kabany MM, McWilliams JP, Kee ST. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016 Jul 7;22(25):5780-5789. PMID: 27433091 |
65. Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ. Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol. 2016 Dec 28;4(4):281-287. PMID: 28097095 |
66. Vidhyarkorn S, Siripongsakun S, Yu J, Sayre J, Agopian VG, Durazo F, Lu DS. Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients. Liver Transpl. 2017 Mar;23(3):324-329. PMID: 27875639 |
67. Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. J Clin Gastroenterol. 2017 Feb;51(2):167-173. PMID: 27548734 |
68. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El Kabany MM, Han SB, Saab S. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Gastroenterol. 2017 Mar 28;5(1):43-49. PMID: 28507926 |
69. Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavirin in Liver Transplant Recipients with Hepatitis C. J Clin Transl Hepatol. 2017 Jun 28;5(2):101-108. PMID: 28660147 |
70. Saab S, Sikavi C, Jimenez M, Viramontes M, Allen R, Challita Y, Mai M, Esmailzadeh N, Grotts J, Choi G, Durazo F, El-Kabany M, Han SH, Moreno E. Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients. J Clin Transl Hepatol. 2017 Dec 28;5(4):335-342. PMID: 29226100 |
71. Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, McWilliams JP, DiNorcia J 3rd, Padia SA, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. American Journal of Gastroenterology. 2018 Aug;113(8);1187-1196. PMID: 29899437 |
72. Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Impact of Sustained Viral Response with Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients. Experimental and Clinical Transplantation. 2018 Aug;16(4):419-424. |
73. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. Journal of Clinical Transplant Hepatology. 2018 Sep 28;6(3):247-250. PMID: 30271735 |
74. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. Journal of Clinical Transplant Hepatology. 2018 Sep 28;6(3):247-250. PMID: 30271735 |
75. Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sudaram V, Noureddin M, Ayoub WS, Durazo FA, Benhammou JN, Enayati P, Elashoff D, Goodman MT, Pisegna J, Hussain S. Microbiome and bile acid profiles in duodenal aspirates from liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatology Research. 2018 Dec;48(13):1108-1117. PMID: 29923681 |
76. Phan J, Ng V, Sheinbaum AJ, French SW, Choi G, El Kabany ME, Durazo FA, Saab S, Tong MJ, Busuttil RW, Han SH. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. Journal of Clinical Gastroenterology. 2019 Apr;53(4):309-313. PMID: 29912756 |
77. Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver Transpl. 2017 Dec;23(12):1519-1530. PMID: 28926171 |
Books, Chapters, and Reviews |
1. Durazo F. Abdominal Tuberculosis. Valenzuela JE and Rodes J (eds), Gastroenterología y Hepatología. Mediterráneo Publisher., 410-416, 1996 |
2. Durazo F. Cholestatic Liver Diseases. Esrailian E (ed), Gut Instincts, A Clinician's Handbook of Digestive and Liver Diseases. SLACK Incorporated, 265-272, 2012. |
3. Durazo FA. Endoscopic Therapy for Esophageal Variceal Hemorrhage. Cameron JL and Cameron AM (ed), Current Surgical Therapy, 11th Edition. Elsevier, 359-361, 2013. |
4. Durazo FA, Tong MJ. Unusual Indications for Liver Transplantation. Busuttil RW and Klintmalm GB (ed), Transplantation of the Liver, 3rd Edition. Elsevier, 256-267 2015. |
5. Durazo FA. Management of Refractory Ascites. Cameron JL and Cameron AM (ed), Current Surgical Therapy, 12th Edition. Elsevier, 412-417 2017. |
6. Durazo FA. Acute Liver Failure in Adults & Children. The Dumont-UCLA Transplant Guide, 4th Edition. UCLA Liver Transplantation, 2018. |
Non-Refereed Journal Publications/Original Papers |
1. Durazo F. Evaluation of Mild Abnormalities of Liver enzymes. The Pulse (Newsletter of the Mullikin Medical Center), September 1994. |
2. Durazo F. Evaluation of Mild Abnormalities of Liver enzymes. The Pulse (Newsletter of the Mullikin Medical Center), September 1994. |
3. Durazo F. Clinical Usefulness of the Carcinoembrionic Antigen. The Pulse (Newsletter of the Mullikin Medical Center), October 1996. |
Abstracts |
1. Durazo F., Valenzuela JE. Effect of Metoclopramide on the Mechanisms of Gastroesophageal Reflux. Abstract submitted to the American Motility Society. Meeting held in Houston, Texas. October 1986. |
2. Selby RR, Korula J, Mateo R, Selby B, Durazo F, Wueste D, Ahluwalia A, Moser J, Genyk Y, Jabbour N. Comparison of the pre-transplant costs and medical acuity between adult cadaveric versus live-donor liver transplant recipients. Abstract, AASLD, 2000 |
3. Kanwal F, Chen D, Saab S, Durazo F, Busuttil R, Han S. Predictors of Post-Liver Transplant Altered Mental Status of Unclear Etiology. Hepatology 2002;36(4): 189A. (AASLD Poster Presentation). |
4. Saab S, De la Rosa P, Nieto J, Durazo F, Han S, Roth B. Costs and Clinical Outcomes of Primary Prophylaxis of Variceal Bleeding in Cirrhotics: A Decision Analytic Model. Abstract, AASLD, 2002. |
5. Karsan H, Lee C, Dong P, Durazo F, Saab S, Han S. Do Transjugular Intrahepatic Portosystemic Shunts (TIPSS) for Refractory Ascites Really Work? Hepatology 2002; 36(4): 533A. |
6. Saab S, Hur, Ibrahim A, Goldstein L, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial R, Framer D, Busuttil R, Lassman C. Discordance between Alanine Aminotransferase and Liver Histology in the Liver Transplant Recipients Treated with Ribavirin Monotherapy for Recurrent Hepatitis C Virus. Hepatology 2002; 36(4):655A. |
7. Saab S, Ghobrial R, Ibrahim A, Han S, Chen P, Farmer D, Durazo F, Yersiz H, Goldstein L, Busuttil R. Hepatitis C Positive Grafts May Be Used in Orthotopic Liver Transplantation: A Matched Analysis. Hepatology 2002: 36(4); 657A. |
8. Saab S, Ly D, Nieto J, Kanwal F, Durazo F, Han S, Busuttil RW. Hepatocellular Carcinoma Surveillance in Patients Awaiting Liver Transplantation Can Be Cost-Effective. Hepatology 2002; 36(4): 717A. |
9. Saab S, Wang VS, Ibrahim AB, Durazo F, Han SH, Farmer DG, Ghobrial RM, Yersiz H, Morrissey M, Goldstein LI, Busuttil RW. MELD Score Can Predict Post-Orthotopic Liver Transplantation One-Year Patient and Graft Survival. Gastroenterology 2003; 124(4 suppl. 1): A694. |
10. Saab S, Wang V, Ibrahim A, Durazo F, Han S, Farmer D, Ghobrial M, Yersiz H, Goldstein L, Busuttil RW. MELD Score Can Predict Post-orthotopic Liver Transplantation One-Year Patient and Graft Survival. American Transplant Congress, Washington, DC, June 2003. |
11. Ghobrial M, Huang YM, Farmer D, Carmody I, Gornbein J, Steadman R, Saab S, Goldstein L, Yersiz H, Durazo F, Han S, Tang L, Busuttil RW. Post-transplant Hepatitis C Recurrence is Influenced by Non-viral Transplant Related Factors: Ten-Year Analysis in over 300 Patients. American Transplant Congress, Washington, DC, June 2003. |
12. Saab S, Chang A, Comulada S, Geevarghese S, Anselmo D, Ghobrial M, Kunder G, Durazo F, Han S, Farmer D, Yersiz H, Goldstein L, Busuttil R. Outcomes of Hepatitis C and Hepatitis B Core Antibody Positive Grafts in Orthotopic Liver Transplantation. American Transplant Congress, Washington, DC, June 2003. |
13. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Farmer DG, Ghobrial RM, Holt CD, Yersiz H, Goldstein LI, Lipshutz GS, Tong MJ, Busuttil RW. Predictors of Mortality and Meld Scores Changes While Waiting for Liver Transplantation. American Journal of Transplantation. 2005, Supp 11: 5, 216-217. |
14. Saab S, Ibrahim AB, Shpaner Z, Brito I, Fraser K, Marehbian J, Durazo F, Han S, Farmer DG, Ghobrial RM, Holt CD, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. Prevalence and Risk Factors for Diabetes Mellitus in Liver Transplant Recipients. American Journal of Transplantation. 2005, Supp 11: 5, 205 |
15. Cameron AM, Ghobrial RM, Gordon SA, Farmer DG, Yersiz H, Hiatt JR, Zimmerman MA, Durazo F, Gornbein J, Busuttil RW. Hepatitis C Recurrence following Liver Transplant is influenced by Non-Viral Factors. American Surgical Association, Boston, MA, April 2006. |
16. Saab S, Wiese C, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil R. Predictors of employment in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, October 2006. |
17. Spiegel B, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan H, Durazo F, Bacon B, Martin P, Younossi Z, Ong SH, Kanwal F. Development and validation of a disease-targeted health-related quality of life (HRQOL) instrument in chronic hepatitis B infection: The HBQOL V1.0. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, October 2006. |
18. Durazo F, Tong MJ, Blatt LB, Corey WG, Lin JH, Han S, Saab S, Busuttil RW. A Comparison of Alphafetoprotein, AFP L3% and Des-Gamma Carboxyprothrombin in Patients with Chronic Hepatitis, Cirrhosis and Hepatocellular Carcinoma. Digestive Diseases Week, Washington, DC, May 2007. |
19. Saab S, Surti B, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil RW. Pre-transplant variables predict quality of life in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2007 |
20. Saab S, Surti B, Ibrahim A, Durazo F, Han S, Yersiz H, Farmer D, Ghobrial M, Goldstein L, Tong M, Busuttil RW. Pre-transplant variables predict quality of life in liver transplant recipients. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2007 |
21. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Endoscopic treatment with maximal stenting for post-liver transplantation nonanastomotic biliary strictures. Shanghai - Hong Kong International Liver Congress, Hong Kong, June 2008. |
22. . |
23. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil RW, Durazo F. Maximal endoscopic stenting for post-liver transplantation anastomotic biliary strictures. Shanghai - Hong Kong International Liver Congress, Hong Kong, June 2008. |
24. Tabibian J, Asham E, Han S, Saab S, Goldstein L, Tong M, Busuttil R, Durazo F. Maximal endoscopic stenting for post-liver transplantation anastomotic biliary strictures. International Liver Transplantation Society Joint Congress, Paris, France, July 2008. |
25. Kanwal F, Asch SM, Kramer JR, Edmundowicz SA, Sanyal AJ, El-Serag HB, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo FA, Bacon BR. Measuring Quality of Care in Patients with Cirrhosis: Development of an Explicit Quality Indicator Set. Gastroenterology, 2009, 136(5 Suppl 1): A10-A11 |
26. Tabibian J, Lazo M, Durazo F, Yeh HC, Clark JM. Nonalcoholic fatty liver disease: Features and differences in an ethno-racially diverse university setting. Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, November 2009. |
27. . |
28. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Nakamura Y, Durazo FA, Tong MJ, Hiatt JR, Busuttil RW. Outcomes Analysis Following Surgical Treatments for Cholangiocarcinoma: A 24-Year Experience in a Single Center. Pacific Coast Surgical Association Kapalua, HI, February 2010. |
29. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Saab S, Han SH, Lassman C, Markovic D, Hiatt J, Busuttil RW. Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma: Analysis of 25-Year Experience in a Single Center. Southern Surgical Association Annual Meeting, West Palm Beach, FL, December 2010. |
30. Ajwichai K, Tan N, Durazo FA, Raman S. Minimizing Bile Duct Injury during Liver Radiofrequency Ablation of Central Liver Masses: Use of Chilled D5W Perfusion Via Endoscopic Nasobiliary Tube. Radiological Society of North America Annual Meeting, Chicago, IL, November 2011. |
31. Lee EW, Kee ST, McWilliams JP, Gomes AS, Durazo F, Saab S, Goldstein L, Busuttil RW. Modified-BRTO (Balloon-occluded Retrograde Transvenous Obliteration) for the treatment of portal hypertensive variceal bleeding. Annual Meeting Society of Interventional Radiology, San Diego, CA, March 2014. |
32. Choi HW, Kee ST, Saab S, Durazo F, Gomes AS, McWilliams JP, Busuttil RW, Lee, EW. Predictors of early mortality after transjugular intrahepatic portosystemic shunt (TIPS) creation for management of refractory ascites. Annual Meeting Society of Interventional Radiology, San Diego, CA, March 2014. |
33. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El Kabany MM, Han SB, Saab S. Decrease of Alpha-Fetoprotein in Patients with Cirrhosis Treated with Direct Acting Agents. Gastroenterology Updates in IBD & Liver Disease, Maui, HI, February 2017. |
34. Nguyen K, Weber A, Choi G, Durazo FA, El Kabany MM, Kang S, Saab S, Han SB. Minimal monitoring in treating Hepatitis C with Direct Acting Antivirals. Gastroenterology Updates in IBD & Liver Disease, Maui, HI, February 2017. |
35. Nguyen K, Konyn P, Choi G, Durazo FA, Han SB, Ramirez S, Saab S, El Kabany MM. Lower sustained virologic response in patients with hepatocellular carcinoma treated for hepatitis C with direct acting antivirals. Annual Meeting European Association for the Study of the Liver, Amsterdam, The Netherlands, April 2017. |
36. Nguyen KT, Konyn P, Darwish T, Choi G, Durazo FA, Han SB, Ramirez S, Saab S, El Kabany M. Lower sustained virologic response in patients with hepatocellular carcinoma treated for hepatitis C treated with direct acting antivirals. Annual Meeting of the American Association for the Study of Liver Diseases, Washington DC, October 2017. |
37. Kamal N, Samala NR, Koh C, Fontana RJ, Stolz A, Durazo FA, Hayashi PH, Hoofnagle JH. Asparaginase-Induced Hepatoxicity. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018. |
38. Yanny BT, Saab S, Durazo FA, Latt NL, Mikhail M, Mitry A, Sahota AK. Eight-Week Hepatitis C Treatment with New Direct Acting Agents Have a Better Safety Profile While Effective in the Geriatric Population without Liver Cirrhosis and Hepatitis C Virus-RNA <6 Million IU/MI. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018. |
39. Yanny BT, Durazo FA, Aziz A, Busuttil RW, Kaldas FM. Largest Series Exploring Implications of Gamma-Glutamyl Transferase Elevation in Post Liver Transplant Recipients, an Analysis of 511 Consecutive Patients. Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, October 2018. |
40. Perumpail RB, Khemichian S, Lakhoo K, Do AL, Choi G, Durazo F, El Kabany M, Saab S, Busuttil RW, Han SB. Tenofovir alafenamide for hepatitis B virus prophylaxis post-liver transplantation is associated with improved renal function: an interim analysis of a multicenter real-world experience. Annual Meeting European Association for the Study of the Liver, Vienna, Austria, April 2019. |
